Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11400164 Immunoconjugates targeting HER2

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

David Y. Jackson0

Shelley Erin Ackerman0

Arthur Lee0

Michael N. Alonso0

Edgar George Engleman0

Date of Patent

August 2, 2022

0

Patent Application Number

174652840

Date Filed

September 2, 2021

0

Patent Citations

US Patent 10662252 Disease therapy by inducing immune response to Trop-2 expressing cells

US Patent 10744204 Conjugated compounds comprising cysteine-engineered antibodies

US Patent 10744206 Compounds and compositions for immunotherapy

US Patent 10780180 Compounds and compositions for immunotherapy

US Patent 10849984 Immunogenic compound

US Patent 10953073 XTEN conjugate compositions and methods of making same

US Patent 10973826 Antibody conjugates comprising toll-like receptor agonist

US Patent 11046781 Anti-HER2 combinations for treating tumors

...

Patent Primary Examiner

Daniel C Gamett

0

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11400164 Immunoconjugates targeting HER2

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool